Aidapak Recalls Niacin Tablets Due to Potential Labeling Mixup
Aidapak Services, LLC is recalling Niacin 500 mg tablets because they may have been mislabeled as Naproxen or Docusate Sodium.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup, which fits the rubric criterion for moderate severity involving minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling Niacin, Tablet, 500 mg, Over The Counter, NDC 00904227260. The recall is due to a labeling mixup where the Niacin tablets may have been mislabeled as Naproxen, Tablet, 500 mg, or Docusate Sodium, Capsule, 250 mg.
The affected Niacin tablets were distributed in Arizona, California, Oregon, and Washington. The recall includes two specific pedigrees: AD52993_10 with an expiration date of 5/20/2014, and W002957 with an expiration date of 6/10/2014. The product quantity is 200 tablets.
Consumers should check their medication labels to ensure they are not holding the affected Niacin tablets. If the product is found, consumers should stop using it and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- NIACIN, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904227260.
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- NIACIN
- Tablet
- 500 mg has the following codes: Pedigree: AD52993_10
- EXP: 5/20/2014
- Pedigree: W002957
- EXP: 6/10/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Niacin TR Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighAidapak Recalls Docusate Sodium Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Naproxen Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Acetaminophen Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Docusate Sodium Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-22